Timothy M. Lestingi
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Cancer therapeutics and mechanisms
Papers in
-
- Prostate Cancer Treatment and Research 15
- Prostate Cancer Diagnosis and Treatment 3
- Oncology 14
- Cancer Treatment and Pharmacology 4
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Everett E. Vokes (2 shared papers)E Gupta (2 shared papers)MJ Ratain (2 shared papers)Jesús Ramı́rez (2 shared papers)Rosemarie Mick (3 shared papers)Xiaolin Wang (1 shared paper)Chadi Nabhan (12 shared papers)Jon Richards (1 shared paper)
- Journals
- Journal of Clinical Oncology (12 papers)British Journal of Cancer (2 papers)Clinical Genitourinary Cancer (2 papers)Urology (1 paper)Human Gene Therapy (1 paper)
- Partner nations
- United States
In The Last Decade
Timothy M. Lestingi
25 papers receiving 812 citations
Peers
Comparison fields: 5 of 66
- Oncology 560
- Molecular Biology 599
- Pharmacology 65
- Toxicology 23
- Pulmonary and Respiratory Medicine 179
Countries citing papers authored by Timothy M. Lestingi
This map shows the geographic impact of Timothy M. Lestingi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Lestingi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Lestingi more than expected).
Fields of papers citing papers by Timothy M. Lestingi
This network shows the impact of papers produced by Timothy M. Lestingi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Lestingi. The network helps show where Timothy M. Lestingi may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy M. Lestingi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. | 1994 | 409 |
| 2 | 1997 | 153 | |
| 3 | 1999 | 74 | |
| 4 | 2013 | 45 | |
| 5 | 2009 | 38 | |
| 6 | 1993 | 20 | |
| 7 | 1994 | 17 | |
| 8 | 2012 | 16 | |
| 9 | 2013 | 15 | |
| 10 | 2002 | 14 | |
| 11 | 2013 | 13 | |
| 12 | 1998 | 7 | |
| 13 | 2015 | 5 | |
| 14 | 2010 | 5 | |
| 15 | 2012 | 3 | |
| 16 | 1996 | 1 | |
| 17 | 2018 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2012 | 1 | |
| 20 | 2009 | 1 |
About Timothy M. Lestingi
Timothy M. Lestingi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Hematology and Immunology, having authored 26 papers that have together received 844 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (4 papers), Multiple Myeloma Research and Treatments (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Oncology (560 citations), Molecular Biology (599 citations), Pharmacology (65 citations), Toxicology (23 citations) and Pulmonary and Respiratory Medicine (179 citations). Timothy M. Lestingi has collaborated with scholars based in United States. Frequent co-authors include Everett E. Vokes, E Gupta, MJ Ratain, Jesús Ramı́rez, Rosemarie Mick, Xiaolin Wang, Chadi Nabhan, Jon Richards, Nilesh Mehta and Jacob D. Bitran. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Genitourinary Cancer, Urology and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.